Zhejiang Haisen Pharmaceutical Co., Ltd. (SHE:001367)

Market Cap	3.06B
Revenue (ttm)	474.19M
Net Income (ttm)	120.39M
Shares Out	100.64M
EPS (ttm)	1.18
PE Ratio	25.75
Forward PE	n/a
Dividend	0.17 (0.56%)
Ex-Dividend Date	n/a

Volume	1,682,479
Average Volume	2,953,116
Open	29.89
Previous Close	29.88
Day's Range	29.40 - 30.11
52-Week Range	21.46 - 33.31
Beta	0.91
RSI	58.05
Earnings Date	Apr 21, 2025

About SHE:001367

Zhejiang Haisen Pharmaceutical Co., Ltd. engages in the research and development, production, and sale of chemical active pharmaceutical ingredient and intermediates in China. The company offers APIs for anti-gastric ulcer, antilipemic agent, antipyretic analgesics, antidepressant, analgesic, antibacterial agent, antipyretic analgesics, histamines drug, and anticonvulsant. It also provides chemical product for intermediates and food additives. Zhejiang Haisen Pharmaceutical Co., Ltd. was founded in 1998 and is based in Dongyang, China.

• Industry: Drug Manufacturers - General
• Sector: Healthcare
• Founded: 1998
• Employees: 663
• Stock Exchange: Shenzhen Stock Exchange
• Ticker Symbol: 001367

Financial Performance

In 2024, SHE:001367's revenue was 471.51 million, an increase of 18.63% compared to the previous year's 397.45 million. Earnings were 122.56 million, an increase of 17.09%.